FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310040229> ?p ?o ?g. }

• W4310040229 abstract "Background Anoikis is a form of programmed cell death or programmed cell death(PCD) for short. Studies suggest that anoikis involves in the decisive steps of tumor progression and cancer cell metastasis and spread, but what part it plays in bladder cancer remains unclear. We sought to screen for anoikis-correlated long non-coding RNA (lncRNA) so that we can build a risk model to understand its ability to predict bladder cancer prognosis and the immune landscape. Methods We screened seven anoikis-related lncRNAs (arlncRNAs) from The Cancer Genome Atlas (TCGA) and designed a risk model. It was validated through ROC curves and clinicopathological correlation analysis, and demonstrated to be an independent factor of prognosis prediction by uni- and multi-COX regression. In the meantime, Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis, immune infiltration, and half-maximal inhibitory concentration prediction (IC50) were implemented with the model. Moreover, we divided bladder cancer patients into three subtypes by consensus clustering analysis to further study the differences in prognosis, immune infiltration level, immune checkpoints, and drug susceptibility. Result We designed a risk model of seven arlncRNAs, and proved its accuracy using ROC curves. COX regression indicated that the model might be an independent prediction factor of bladder cancer prognosis. KEGG enrichment analysis showed it was enriched in tumors and immune-related pathways among the people at high risk. Immune correlation analysis and drug susceptibility results indicated that it had higher immune infiltration and might have a better immunotherapy efficacy for high-risk groups. Of the three subtypes classified by consensus clustering analysis, cluster 3 revealed a positive prognosis, and cluster 2 showed the highest level of immune infiltration and was sensitive to most chemistries. This is helpful for us to discover more precise immunotherapy for bladder cancer patients. Conclusion In a nutshell, we found seven arlncRNAs and built a risk model that can identify different bladder cancer subtypes and predict the prognosis of bladder cancer patients. Immune-related and drug sensitivity researches demonstrate it can provide individual therapeutic schedule with greater precision for bladder cancer patients." @default.
• W4310040229 created "2022-11-30" @default.
• W4310040229 creator A5012278873 @default.
• W4310040229 creator A5019056174 @default.
• W4310040229 creator A5028915287 @default.
• W4310040229 creator A5031553447 @default.
• W4310040229 creator A5032396875 @default.
• W4310040229 creator A5037373216 @default.
• W4310040229 creator A5037815607 @default.
• W4310040229 creator A5039481707 @default.
• W4310040229 creator A5047434744 @default.
• W4310040229 creator A5056248574 @default.
• W4310040229 creator A5072853454 @default.
• W4310040229 creator A5086664647 @default.
• W4310040229 date "2022-11-25" @default.
• W4310040229 modified "2023-09-28" @default.
• W4310040229 title "Comprehensive analysis of anoikis-related long non-coding RNA immune infiltration in patients with bladder cancer and immunotherapy" @default.
• W4310040229 cites W1599695598 @default.
• W4310040229 cites W1971156557 @default.
• W4310040229 cites W1981393628 @default.
• W4310040229 cites W1982048464 @default.
• W4310040229 cites W2022199909 @default.
• W4310040229 cites W2081810700 @default.
• W4310040229 cites W2091823826 @default.
• W4310040229 cites W2115124692 @default.
• W4310040229 cites W2128431628 @default.
• W4310040229 cites W2144884298 @default.
• W4310040229 cites W2509675510 @default.
• W4310040229 cites W2570763587 @default.
• W4310040229 cites W2734322281 @default.
• W4310040229 cites W2735687500 @default.
• W4310040229 cites W2945882072 @default.
• W4310040229 cites W2971451528 @default.
• W4310040229 cites W2980759500 @default.
• W4310040229 cites W3000233373 @default.
• W4310040229 cites W3011697946 @default.
• W4310040229 cites W3078201066 @default.
• W4310040229 cites W3092129070 @default.
• W4310040229 cites W3108775243 @default.
• W4310040229 cites W3118066077 @default.
• W4310040229 cites W3120849050 @default.
• W4310040229 cites W3127307282 @default.
• W4310040229 cites W3166551908 @default.
• W4310040229 cites W3184948435 @default.
• W4310040229 cites W3207233727 @default.
• W4310040229 cites W4200542640 @default.
• W4310040229 cites W4212977110 @default.
• W4310040229 cites W4221043859 @default.
• W4310040229 doi "https://doi.org/10.3389/fimmu.2022.1055304" @default.
• W4310040229 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36505486" @default.
• W4310040229 hasPublicationYear "2022" @default.
• W4310040229 type Work @default.
• W4310040229 citedByCount "4" @default.
• W4310040229 countsByYear W43100402292023 @default.
• W4310040229 crossrefType "journal-article" @default.
• W4310040229 hasAuthorship W4310040229A5012278873 @default.
• W4310040229 hasAuthorship W4310040229A5019056174 @default.
• W4310040229 hasAuthorship W4310040229A5028915287 @default.
• W4310040229 hasAuthorship W4310040229A5031553447 @default.
• W4310040229 hasAuthorship W4310040229A5032396875 @default.
• W4310040229 hasAuthorship W4310040229A5037373216 @default.
• W4310040229 hasAuthorship W4310040229A5037815607 @default.
• W4310040229 hasAuthorship W4310040229A5039481707 @default.
• W4310040229 hasAuthorship W4310040229A5047434744 @default.
• W4310040229 hasAuthorship W4310040229A5056248574 @default.
• W4310040229 hasAuthorship W4310040229A5072853454 @default.
• W4310040229 hasAuthorship W4310040229A5086664647 @default.
• W4310040229 hasBestOaLocation W43100402291 @default.
• W4310040229 hasConcept C104317684 @default.
• W4310040229 hasConcept C121608353 @default.
• W4310040229 hasConcept C126322002 @default.
• W4310040229 hasConcept C143998085 @default.
• W4310040229 hasConcept C150194340 @default.
• W4310040229 hasConcept C152000582 @default.
• W4310040229 hasConcept C152724338 @default.
• W4310040229 hasConcept C162317418 @default.
• W4310040229 hasConcept C203014093 @default.
• W4310040229 hasConcept C2777701055 @default.
• W4310040229 hasConcept C2779013556 @default.
• W4310040229 hasConcept C2780352672 @default.
• W4310040229 hasConcept C502942594 @default.
• W4310040229 hasConcept C50382708 @default.
• W4310040229 hasConcept C54355233 @default.
• W4310040229 hasConcept C62203573 @default.
• W4310040229 hasConcept C67705224 @default.
• W4310040229 hasConcept C71924100 @default.
• W4310040229 hasConcept C86803240 @default.
• W4310040229 hasConcept C8891405 @default.
• W4310040229 hasConceptScore W4310040229C104317684 @default.
• W4310040229 hasConceptScore W4310040229C121608353 @default.
• W4310040229 hasConceptScore W4310040229C126322002 @default.
• W4310040229 hasConceptScore W4310040229C143998085 @default.
• W4310040229 hasConceptScore W4310040229C150194340 @default.
• W4310040229 hasConceptScore W4310040229C152000582 @default.
• W4310040229 hasConceptScore W4310040229C152724338 @default.
• W4310040229 hasConceptScore W4310040229C162317418 @default.
• W4310040229 hasConceptScore W4310040229C203014093 @default.
• W4310040229 hasConceptScore W4310040229C2777701055 @default.
• W4310040229 hasConceptScore W4310040229C2779013556 @default.
• W4310040229 hasConceptScore W4310040229C2780352672 @default.

• next